We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GBLI:NASDAQGlobal Indemnity Group, LLC Analysis

Data as of 2026-09-02 - not real-time

$29.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Global Indemnity Group, LLC is priced at $29.00, and its moving averages give no clean directional read — the structure is neutral. Across the trailing 30 sessions it gained 7.4%. With RSI at 58.6 the momentum picture is neutral, alongside a bullish MACD signal. Watch $25.34 as support and $29.62 as the nearer resistance level.
On valuation the read is undervalued — earnings multiple of 12.3 versus a 16.7 sector average, below the peer group. The average analyst target implies 69.0% above today's level. Revenue is growing at 5.1% on a 7.5% profit margin. The 4.73% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 42.9%, a beta of 0.12 and a maximum drawdown of 19.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.

Top Market Events

WILMINGTON, Del., July 28, 2026 GLOBE NEWSWIRE -- Global Indemnity Group, LLC NASDAQ:GBLI 'GBLI” announced today that...OLDWICK, N.J., August 07, 2026--AM Best has affirmed the Financial Strength Rating FSR of A Excellent and the Long-Term...GBLI reports improved combined ratio and investment yields, while navigating elevated expenses and competitive...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 27.67
  • MACD momentum is positive
  • 30-day price change of +7.4%

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 12.3 versus sector average of 16.7
  • Trading above the 200-day average of 27.67
  • Analyst targets imply +69.0% versus the current price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 12.3 versus sector average of 16.7
  • Analyst targets imply +69.0% versus the current price
  • 30-day volatility of 42.9%

Key Metrics & Analysis

Financial Health

Revenue Growth5.10%
Profit Margin7.52%
P/E Ratio12.3
ROE4.88%
ROA1.65%
Debt/Equity1.09
P/B Ratio0.6
Op. Cash Flow$-34016000
Free Cash Flow$744.0M
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI58.6
Support$25.34
Resistance$29.62
MA 20$28.04
MA 50$27.02
MA 200$27.67
MACDBullish
VolumeIncreasing
Fear & Greed Index92.25

Valuation

Fair Value$808.36
Target Price$49.00
Upside/Downside68.97%
GradeUndervalued
TypeValue
Dividend Yield4.73%

Risk Assessment

Beta0.12
Volatility42.88%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.